Just as organizations learned the costs of implementing ICD-10 were likely higher than previously realized, now there is a new headache on the horizon: The transition to ICD-10 may also lead to information and financial losses,  according to a study published in the Journal of Oncology Practice. {read more here}

Individuals who tested positive for beta amyloid on florbetapir-PET brain scans were more likely to decline cognitively over a three-year period than those with a negative scan, in a study published online March 11 in Molecular Psychiatry. {read more here}

18-Fluorodeoxyglucose-positron-emission tomography shows promise as a diagnostic and prognostic test for amyotrophic lateral sclerosis (ALS), according to new findings released online March 10 in JAMA Neurology. {read more here}

PET provides more detail than perfusion-weighted MRI about the boundaries and metabolic function of glioma tumors, according to a study published online Feb. 27 in the Journal of Nuclear Medicine . {read more here}